nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibutilide—KCNH6—prostate gland—prostate cancer	0.0202	0.0831	CbGeAlD
Ibutilide—CACNB1—prostate gland—prostate cancer	0.0201	0.0825	CbGeAlD
Ibutilide—KCNK1—prostate gland—prostate cancer	0.0169	0.0696	CbGeAlD
Ibutilide—KCNK6—testis—prostate cancer	0.0168	0.0692	CbGeAlD
Ibutilide—KCNK1—seminal vesicle—prostate cancer	0.0143	0.0588	CbGeAlD
Ibutilide—KCNH6—renal system—prostate cancer	0.0138	0.0567	CbGeAlD
Ibutilide—KCNH7—testis—prostate cancer	0.0125	0.0514	CbGeAlD
Ibutilide—CACNA2D1—prostate gland—prostate cancer	0.0121	0.0499	CbGeAlD
Ibutilide—KCNK1—renal system—prostate cancer	0.0115	0.0474	CbGeAlD
Ibutilide—KCNK1—urethra—prostate cancer	0.0113	0.0466	CbGeAlD
Ibutilide—CACNA1C—prostate gland—prostate cancer	0.0104	0.0429	CbGeAlD
Ibutilide—Cardiac failure congestive—Estramustine—prostate cancer	0.00903	0.0261	CcSEcCtD
Ibutilide—CACNB1—testis—prostate cancer	0.00884	0.0363	CbGeAlD
Ibutilide—Sinus bradycardia—Mitoxantrone—prostate cancer	0.00757	0.0219	CcSEcCtD
Ibutilide—KCNK1—testis—prostate cancer	0.00746	0.0306	CbGeAlD
Ibutilide—CACNB1—lymph node—prostate cancer	0.00641	0.0263	CbGeAlD
Ibutilide—Sinus tachycardia—Docetaxel—prostate cancer	0.00637	0.0184	CcSEcCtD
Ibutilide—CACNA2D1—bone marrow—prostate cancer	0.00626	0.0257	CbGeAlD
Ibutilide—KCNH2—prostate gland—prostate cancer	0.00622	0.0255	CbGeAlD
Ibutilide—Sinus tachycardia—Capecitabine—prostate cancer	0.00617	0.0178	CcSEcCtD
Ibutilide—Cardiac failure congestive—Bicalutamide—prostate cancer	0.00578	0.0167	CcSEcCtD
Ibutilide—Orthostatic hypotension—Cabazitaxel—prostate cancer	0.00559	0.0161	CcSEcCtD
Ibutilide—KCNK1—lymph node—prostate cancer	0.00541	0.0222	CbGeAlD
Ibutilide—CACNA2D1—testis—prostate cancer	0.00535	0.022	CbGeAlD
Ibutilide—KCNH2—seminal vesicle—prostate cancer	0.00526	0.0216	CbGeAlD
Ibutilide—Renal failure—Degarelix—prostate cancer	0.00492	0.0142	CcSEcCtD
Ibutilide—Sotalol—ADRB2—prostate cancer	0.00476	0.745	CrCbGaD
Ibutilide—Supraventricular extrasystoles—Epirubicin—prostate cancer	0.00465	0.0134	CcSEcCtD
Ibutilide—Renal failure—Cabazitaxel—prostate cancer	0.00463	0.0134	CcSEcCtD
Ibutilide—CACNA1C—testis—prostate cancer	0.0046	0.0189	CbGeAlD
Ibutilide—Ventricular extrasystoles—Estradiol—prostate cancer	0.00441	0.0128	CcSEcCtD
Ibutilide—Supraventricular extrasystoles—Doxorubicin—prostate cancer	0.0043	0.0124	CcSEcCtD
Ibutilide—Sinus tachycardia—Epirubicin—prostate cancer	0.0043	0.0124	CcSEcCtD
Ibutilide—KCNH2—renal system—prostate cancer	0.00424	0.0174	CbGeAlD
Ibutilide—KCNH2—urethra—prostate cancer	0.00416	0.0171	CbGeAlD
Ibutilide—Hypertension—Abiraterone—prostate cancer	0.00414	0.012	CcSEcCtD
Ibutilide—Cardiac failure congestive—Goserelin—prostate cancer	0.00402	0.0116	CcSEcCtD
Ibutilide—Cardiac failure congestive—Conjugated Estrogens—prostate cancer	0.00399	0.0115	CcSEcCtD
Ibutilide—Sinus tachycardia—Doxorubicin—prostate cancer	0.00398	0.0115	CcSEcCtD
Ibutilide—Syncope—Nilutamide—prostate cancer	0.00392	0.0113	CcSEcCtD
Ibutilide—KCNJ11—lymph node—prostate cancer	0.00392	0.0161	CbGeAlD
Ibutilide—Supraventricular tachycardia—Docetaxel—prostate cancer	0.00392	0.0113	CcSEcCtD
Ibutilide—CACNA2D1—lymph node—prostate cancer	0.00388	0.0159	CbGeAlD
Ibutilide—Loss of consciousness—Nilutamide—prostate cancer	0.00385	0.0111	CcSEcCtD
Ibutilide—Supraventricular tachycardia—Capecitabine—prostate cancer	0.00379	0.011	CcSEcCtD
Ibutilide—Hypertension—Nilutamide—prostate cancer	0.00378	0.0109	CcSEcCtD
Ibutilide—Hypertension—Flutamide—prostate cancer	0.00376	0.0109	CcSEcCtD
Ibutilide—Bradycardia—Bicalutamide—prostate cancer	0.00369	0.0107	CcSEcCtD
Ibutilide—Palpitations—Estradiol valerate/Dienogest—prostate cancer	0.00363	0.0105	CcSEcCtD
Ibutilide—Shock—Nilutamide—prostate cancer	0.00351	0.0102	CcSEcCtD
Ibutilide—Palpitations—Degarelix—prostate cancer	0.00345	0.00999	CcSEcCtD
Ibutilide—Bundle branch block—Epirubicin—prostate cancer	0.00343	0.00992	CcSEcCtD
Ibutilide—Hypertension—Degarelix—prostate cancer	0.00338	0.00976	CcSEcCtD
Ibutilide—CACNA1C—lymph node—prostate cancer	0.00333	0.0137	CbGeAlD
Ibutilide—KCNH2—bone marrow—prostate cancer	0.0032	0.0132	CbGeAlD
Ibutilide—Hypertension—Cabazitaxel—prostate cancer	0.00318	0.00919	CcSEcCtD
Ibutilide—Bundle branch block—Doxorubicin—prostate cancer	0.00317	0.00918	CcSEcCtD
Ibutilide—Hypotension—Degarelix—prostate cancer	0.00298	0.00862	CcSEcCtD
Ibutilide—Cardiac failure congestive—Mitoxantrone—prostate cancer	0.00297	0.00859	CcSEcCtD
Ibutilide—Tachycardia—Cabazitaxel—prostate cancer	0.00293	0.00848	CcSEcCtD
Ibutilide—Syncope—Bicalutamide—prostate cancer	0.00283	0.00819	CcSEcCtD
Ibutilide—Hypotension—Cabazitaxel—prostate cancer	0.00281	0.00812	CcSEcCtD
Ibutilide—Loss of consciousness—Bicalutamide—prostate cancer	0.00278	0.00803	CcSEcCtD
Ibutilide—Renal failure—Goserelin—prostate cancer	0.00276	0.00799	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Capecitabine—prostate cancer	0.00275	0.00795	CcSEcCtD
Ibutilide—KCNH2—testis—prostate cancer	0.00274	0.0113	CbGeAlD
Ibutilide—Renal failure—Conjugated Estrogens—prostate cancer	0.00274	0.00792	CcSEcCtD
Ibutilide—Hypertension—Bicalutamide—prostate cancer	0.00273	0.00788	CcSEcCtD
Ibutilide—Dizziness—Estrone—prostate cancer	0.00254	0.00735	CcSEcCtD
Ibutilide—Shock—Bicalutamide—prostate cancer	0.00254	0.00733	CcSEcCtD
Ibutilide—Headache—Estramustine—prostate cancer	0.00252	0.00729	CcSEcCtD
Ibutilide—Cardiac failure congestive—Etoposide—prostate cancer	0.00247	0.00715	CcSEcCtD
Ibutilide—Headache—Estrone—prostate cancer	0.00241	0.00696	CcSEcCtD
Ibutilide—Nausea—Estramustine—prostate cancer	0.00239	0.00691	CcSEcCtD
Ibutilide—Dizziness—Nilutamide—prostate cancer	0.00236	0.00683	CcSEcCtD
Ibutilide—Dizziness—Flutamide—prostate cancer	0.00235	0.0068	CcSEcCtD
Ibutilide—Ventricular arrhythmia—Epirubicin—prostate cancer	0.00234	0.00676	CcSEcCtD
Ibutilide—Nausea—Estrone—prostate cancer	0.00228	0.0066	CcSEcCtD
Ibutilide—Headache—Nilutamide—prostate cancer	0.00224	0.00647	CcSEcCtD
Ibutilide—Headache—Flutamide—prostate cancer	0.00223	0.00644	CcSEcCtD
Ibutilide—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00222	0.00641	CcSEcCtD
Ibutilide—Ventricular arrhythmia—Doxorubicin—prostate cancer	0.00216	0.00626	CcSEcCtD
Ibutilide—Nausea—Nilutamide—prostate cancer	0.00212	0.00613	CcSEcCtD
Ibutilide—Nausea—Flutamide—prostate cancer	0.00211	0.00611	CcSEcCtD
Ibutilide—Dizziness—Degarelix—prostate cancer	0.00211	0.0061	CcSEcCtD
Ibutilide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.0021	0.00608	CcSEcCtD
Ibutilide—Cardiac failure congestive—Docetaxel—prostate cancer	0.00205	0.00594	CcSEcCtD
Ibutilide—Renal failure—Mitoxantrone—prostate cancer	0.00204	0.0059	CcSEcCtD
Ibutilide—Headache—Degarelix—prostate cancer	0.002	0.00578	CcSEcCtD
Ibutilide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00576	CcSEcCtD
Ibutilide—Dizziness—Cabazitaxel—prostate cancer	0.00199	0.00575	CcSEcCtD
Ibutilide—KCNH2—lymph node—prostate cancer	0.00199	0.00816	CbGeAlD
Ibutilide—Syncope—Conjugated Estrogens—prostate cancer	0.00195	0.00564	CcSEcCtD
Ibutilide—Palpitations—Goserelin—prostate cancer	0.00194	0.00561	CcSEcCtD
Ibutilide—Palpitations—Conjugated Estrogens—prostate cancer	0.00192	0.00556	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Epirubicin—prostate cancer	0.00192	0.00554	CcSEcCtD
Ibutilide—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00191	0.00553	CcSEcCtD
Ibutilide—Bradycardia—Mitoxantrone—prostate cancer	0.0019	0.00549	CcSEcCtD
Ibutilide—Hypertension—Goserelin—prostate cancer	0.0019	0.00548	CcSEcCtD
Ibutilide—Nausea—Degarelix—prostate cancer	0.0019	0.00548	CcSEcCtD
Ibutilide—Headache—Cabazitaxel—prostate cancer	0.00188	0.00544	CcSEcCtD
Ibutilide—Nausea—Cabazitaxel—prostate cancer	0.00179	0.00516	CcSEcCtD
Ibutilide—Atrioventricular block—Epirubicin—prostate cancer	0.00178	0.00516	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Doxorubicin—prostate cancer	0.00177	0.00513	CcSEcCtD
Ibutilide—Cardiac failure congestive—Prednisone—prostate cancer	0.00177	0.00512	CcSEcCtD
Ibutilide—Shock—Goserelin—prostate cancer	0.00176	0.0051	CcSEcCtD
Ibutilide—Tachycardia—Goserelin—prostate cancer	0.00175	0.00506	CcSEcCtD
Ibutilide—Shock—Conjugated Estrogens—prostate cancer	0.00175	0.00505	CcSEcCtD
Ibutilide—Tachycardia—Conjugated Estrogens—prostate cancer	0.00173	0.00501	CcSEcCtD
Ibutilide—Ventricular tachycardia—Epirubicin—prostate cancer	0.00173	0.00501	CcSEcCtD
Ibutilide—Dizziness—Bicalutamide—prostate cancer	0.0017	0.00493	CcSEcCtD
Ibutilide—Orthostatic hypotension—Docetaxel—prostate cancer	0.0017	0.00492	CcSEcCtD
Ibutilide—Renal failure—Etoposide—prostate cancer	0.0017	0.00491	CcSEcCtD
Ibutilide—Hypotension—Goserelin—prostate cancer	0.00168	0.00484	CcSEcCtD
Ibutilide—Hypotension—Conjugated Estrogens—prostate cancer	0.00166	0.0048	CcSEcCtD
Ibutilide—Atrioventricular block—Doxorubicin—prostate cancer	0.00165	0.00477	CcSEcCtD
Ibutilide—Orthostatic hypotension—Capecitabine—prostate cancer	0.00165	0.00476	CcSEcCtD
Ibutilide—Dronedarone—CYP3A4—prostate cancer	0.00163	0.255	CrCbGaD
Ibutilide—Headache—Bicalutamide—prostate cancer	0.00162	0.00467	CcSEcCtD
Ibutilide—Ventricular tachycardia—Doxorubicin—prostate cancer	0.0016	0.00463	CcSEcCtD
Ibutilide—Syncope—Estradiol—prostate cancer	0.00156	0.00452	CcSEcCtD
Ibutilide—Palpitations—Estradiol—prostate cancer	0.00154	0.00445	CcSEcCtD
Ibutilide—Nausea—Bicalutamide—prostate cancer	0.00153	0.00443	CcSEcCtD
Ibutilide—Loss of consciousness—Estradiol—prostate cancer	0.00153	0.00443	CcSEcCtD
Ibutilide—Hypertension—Estradiol—prostate cancer	0.0015	0.00435	CcSEcCtD
Ibutilide—Dizziness—Ethinyl Estradiol—prostate cancer	0.00144	0.00417	CcSEcCtD
Ibutilide—Renal failure—Docetaxel—prostate cancer	0.00141	0.00408	CcSEcCtD
Ibutilide—Hypertension—Mitoxantrone—prostate cancer	0.0014	0.00405	CcSEcCtD
Ibutilide—Shock—Estradiol—prostate cancer	0.0014	0.00404	CcSEcCtD
Ibutilide—Tachycardia—Estradiol—prostate cancer	0.00139	0.00401	CcSEcCtD
Ibutilide—Cardiac failure congestive—Epirubicin—prostate cancer	0.00139	0.00401	CcSEcCtD
Ibutilide—Renal failure—Capecitabine—prostate cancer	0.00137	0.00395	CcSEcCtD
Ibutilide—Headache—Ethinyl Estradiol—prostate cancer	0.00137	0.00395	CcSEcCtD
Ibutilide—Shock—Mitoxantrone—prostate cancer	0.0013	0.00377	CcSEcCtD
Ibutilide—Nausea—Ethinyl Estradiol—prostate cancer	0.00129	0.00374	CcSEcCtD
Ibutilide—Tachycardia—Mitoxantrone—prostate cancer	0.00129	0.00374	CcSEcCtD
Ibutilide—Cardiac failure congestive—Doxorubicin—prostate cancer	0.00128	0.00371	CcSEcCtD
Ibutilide—Bradycardia—Capecitabine—prostate cancer	0.00127	0.00367	CcSEcCtD
Ibutilide—Hypotension—Mitoxantrone—prostate cancer	0.00124	0.00358	CcSEcCtD
Ibutilide—Loss of consciousness—Etoposide—prostate cancer	0.00119	0.00343	CcSEcCtD
Ibutilide—Dizziness—Goserelin—prostate cancer	0.00119	0.00343	CcSEcCtD
Ibutilide—Dizziness—Conjugated Estrogens—prostate cancer	0.00117	0.0034	CcSEcCtD
Ibutilide—Hypertension—Etoposide—prostate cancer	0.00117	0.00337	CcSEcCtD
Ibutilide—Orthostatic hypotension—Epirubicin—prostate cancer	0.00115	0.00332	CcSEcCtD
Ibutilide—Bradycardia—Prednisone—prostate cancer	0.00113	0.00327	CcSEcCtD
Ibutilide—Headache—Goserelin—prostate cancer	0.00112	0.00325	CcSEcCtD
Ibutilide—Headache—Conjugated Estrogens—prostate cancer	0.00111	0.00322	CcSEcCtD
Ibutilide—Tachycardia—Etoposide—prostate cancer	0.00108	0.00311	CcSEcCtD
Ibutilide—Nausea—Goserelin—prostate cancer	0.00107	0.00308	CcSEcCtD
Ibutilide—Orthostatic hypotension—Doxorubicin—prostate cancer	0.00106	0.00307	CcSEcCtD
Ibutilide—Nausea—Conjugated Estrogens—prostate cancer	0.00106	0.00305	CcSEcCtD
Ibutilide—Hypotension—Etoposide—prostate cancer	0.00103	0.00298	CcSEcCtD
Ibutilide—Syncope—Docetaxel—prostate cancer	0.00101	0.00291	CcSEcCtD
Ibutilide—Palpitations—Docetaxel—prostate cancer	0.000992	0.00287	CcSEcCtD
Ibutilide—Loss of consciousness—Docetaxel—prostate cancer	0.000986	0.00285	CcSEcCtD
Ibutilide—Syncope—Capecitabine—prostate cancer	0.000974	0.00282	CcSEcCtD
Ibutilide—Hypertension—Docetaxel—prostate cancer	0.000969	0.0028	CcSEcCtD
Ibutilide—Palpitations—Capecitabine—prostate cancer	0.00096	0.00278	CcSEcCtD
Ibutilide—Loss of consciousness—Capecitabine—prostate cancer	0.000955	0.00276	CcSEcCtD
Ibutilide—Renal failure—Epirubicin—prostate cancer	0.000952	0.00275	CcSEcCtD
Ibutilide—Dizziness—Estradiol—prostate cancer	0.00094	0.00272	CcSEcCtD
Ibutilide—Hypertension—Capecitabine—prostate cancer	0.000938	0.00271	CcSEcCtD
Ibutilide—Shock—Docetaxel—prostate cancer	0.000901	0.0026	CcSEcCtD
Ibutilide—Tachycardia—Docetaxel—prostate cancer	0.000894	0.00258	CcSEcCtD
Ibutilide—Headache—Estradiol—prostate cancer	0.000891	0.00257	CcSEcCtD
Ibutilide—Bradycardia—Epirubicin—prostate cancer	0.000885	0.00256	CcSEcCtD
Ibutilide—Renal failure—Doxorubicin—prostate cancer	0.000881	0.00255	CcSEcCtD
Ibutilide—Shock—Capecitabine—prostate cancer	0.000872	0.00252	CcSEcCtD
Ibutilide—Syncope—Prednisone—prostate cancer	0.000868	0.00251	CcSEcCtD
Ibutilide—Tachycardia—Capecitabine—prostate cancer	0.000865	0.0025	CcSEcCtD
Ibutilide—Hypotension—Docetaxel—prostate cancer	0.000856	0.00247	CcSEcCtD
Ibutilide—Loss of consciousness—Prednisone—prostate cancer	0.000851	0.00246	CcSEcCtD
Ibutilide—Nausea—Estradiol—prostate cancer	0.000845	0.00244	CcSEcCtD
Ibutilide—Hypertension—Prednisone—prostate cancer	0.000836	0.00242	CcSEcCtD
Ibutilide—Headache—Mitoxantrone—prostate cancer	0.00083	0.0024	CcSEcCtD
Ibutilide—Hypotension—Capecitabine—prostate cancer	0.000829	0.0024	CcSEcCtD
Ibutilide—Bradycardia—Doxorubicin—prostate cancer	0.000819	0.00237	CcSEcCtD
Ibutilide—Nausea—Mitoxantrone—prostate cancer	0.000787	0.00227	CcSEcCtD
Ibutilide—Shock—Prednisone—prostate cancer	0.000777	0.00225	CcSEcCtD
Ibutilide—Tachycardia—Prednisone—prostate cancer	0.000771	0.00223	CcSEcCtD
Ibutilide—Dizziness—Etoposide—prostate cancer	0.000729	0.00211	CcSEcCtD
Ibutilide—Headache—Etoposide—prostate cancer	0.00069	0.002	CcSEcCtD
Ibutilide—Syncope—Epirubicin—prostate cancer	0.000679	0.00196	CcSEcCtD
Ibutilide—Palpitations—Epirubicin—prostate cancer	0.000669	0.00193	CcSEcCtD
Ibutilide—Loss of consciousness—Epirubicin—prostate cancer	0.000665	0.00192	CcSEcCtD
Ibutilide—Nausea—Etoposide—prostate cancer	0.000655	0.00189	CcSEcCtD
Ibutilide—Hypertension—Epirubicin—prostate cancer	0.000653	0.00189	CcSEcCtD
Ibutilide—Syncope—Doxorubicin—prostate cancer	0.000628	0.00182	CcSEcCtD
Ibutilide—Palpitations—Doxorubicin—prostate cancer	0.000619	0.00179	CcSEcCtD
Ibutilide—Loss of consciousness—Doxorubicin—prostate cancer	0.000616	0.00178	CcSEcCtD
Ibutilide—Shock—Epirubicin—prostate cancer	0.000608	0.00176	CcSEcCtD
Ibutilide—Dizziness—Docetaxel—prostate cancer	0.000606	0.00175	CcSEcCtD
Ibutilide—Hypertension—Doxorubicin—prostate cancer	0.000605	0.00175	CcSEcCtD
Ibutilide—Tachycardia—Epirubicin—prostate cancer	0.000603	0.00174	CcSEcCtD
Ibutilide—Dizziness—Capecitabine—prostate cancer	0.000586	0.00169	CcSEcCtD
Ibutilide—Hypotension—Epirubicin—prostate cancer	0.000577	0.00167	CcSEcCtD
Ibutilide—Headache—Docetaxel—prostate cancer	0.000574	0.00166	CcSEcCtD
Ibutilide—Shock—Doxorubicin—prostate cancer	0.000562	0.00163	CcSEcCtD
Ibutilide—Tachycardia—Doxorubicin—prostate cancer	0.000558	0.00161	CcSEcCtD
Ibutilide—Headache—Capecitabine—prostate cancer	0.000555	0.00161	CcSEcCtD
Ibutilide—Nausea—Docetaxel—prostate cancer	0.000544	0.00157	CcSEcCtD
Ibutilide—Hypotension—Doxorubicin—prostate cancer	0.000534	0.00154	CcSEcCtD
Ibutilide—Nausea—Capecitabine—prostate cancer	0.000527	0.00152	CcSEcCtD
Ibutilide—Dizziness—Prednisone—prostate cancer	0.000522	0.00151	CcSEcCtD
Ibutilide—Headache—Prednisone—prostate cancer	0.000495	0.00143	CcSEcCtD
Ibutilide—Nausea—Prednisone—prostate cancer	0.000469	0.00136	CcSEcCtD
Ibutilide—Dizziness—Epirubicin—prostate cancer	0.000408	0.00118	CcSEcCtD
Ibutilide—Headache—Epirubicin—prostate cancer	0.000387	0.00112	CcSEcCtD
Ibutilide—Dizziness—Doxorubicin—prostate cancer	0.000378	0.00109	CcSEcCtD
Ibutilide—Nausea—Epirubicin—prostate cancer	0.000367	0.00106	CcSEcCtD
Ibutilide—Headache—Doxorubicin—prostate cancer	0.000358	0.00104	CcSEcCtD
Ibutilide—Nausea—Doxorubicin—prostate cancer	0.00034	0.000981	CcSEcCtD
Ibutilide—CACNA1C—Metabolism—GSTM3—prostate cancer	0.000236	0.000583	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NAGLU—prostate cancer	0.000236	0.000583	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—MBTPS1—prostate cancer	0.000236	0.000583	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PGAM2—prostate cancer	0.000236	0.000583	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—VAV3—prostate cancer	0.000235	0.000582	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—ERBB2—prostate cancer	0.000235	0.000582	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—KDR—prostate cancer	0.000235	0.00058	CbGpPWpGaD
Ibutilide—CACNA1C—NCAM signaling for neurite out-growth—IL6—prostate cancer	0.000228	0.000565	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AMACR—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP3A43—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—DEGS1—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SRD5A2—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NAT1—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Ibutilide—KCNH7—Circadian rythm related genes—IL6—prostate cancer	0.000222	0.000549	CbGpPWpGaD
Ibutilide—CACNA1C—Alzheimers Disease—TP53—prostate cancer	0.000221	0.000547	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—HPGD—prostate cancer	0.000218	0.000539	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—B4GALT4—prostate cancer	0.000218	0.000539	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—NCOA2—prostate cancer	0.000215	0.000533	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HSD17B1—prostate cancer	0.000213	0.000528	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—GSK3B—prostate cancer	0.000207	0.000513	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—TNFRSF21—prostate cancer	0.000205	0.000507	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000205	0.000507	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—INS—prostate cancer	0.000205	0.000506	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—ITGB3—prostate cancer	0.000202	0.0005	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—MMP9—prostate cancer	0.000202	0.000499	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—CREBBP—prostate cancer	0.0002	0.000496	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—MTAP—prostate cancer	0.000199	0.000493	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP7B1—prostate cancer	0.000199	0.000493	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000196	0.000485	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SRD5A1—prostate cancer	0.000194	0.000481	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SULT1E1—prostate cancer	0.000194	0.000481	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—MMP2—prostate cancer	0.000192	0.000474	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—MAP2K1—prostate cancer	0.000191	0.000473	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—B4GALT4—prostate cancer	0.00019	0.00047	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HPGD—prostate cancer	0.00019	0.00047	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000189	0.000468	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—SRC—prostate cancer	0.000186	0.00046	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ACSL4—prostate cancer	0.000185	0.000458	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—HSD17B3—prostate cancer	0.000185	0.000458	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—PRKCQ—prostate cancer	0.000183	0.000453	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—FGF2—prostate cancer	0.000182	0.00045	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—NCOA1—prostate cancer	0.000182	0.000449	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—VEGFA—prostate cancer	0.000181	0.000448	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—TNFRSF21—prostate cancer	0.000179	0.000442	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—UMPS—prostate cancer	0.000178	0.000439	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PHGDH—prostate cancer	0.000178	0.000439	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ARG2—prostate cancer	0.000178	0.000439	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000176	0.000435	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—JAK2—prostate cancer	0.000174	0.000431	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—LDHB—prostate cancer	0.000174	0.000431	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—FGF10—prostate cancer	0.000174	0.00043	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—MTAP—prostate cancer	0.000174	0.00043	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP7B1—prostate cancer	0.000174	0.00043	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—RXRA—prostate cancer	0.000173	0.000427	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—KDR—prostate cancer	0.000172	0.000425	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP3A5—prostate cancer	0.000171	0.000423	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SULT1E1—prostate cancer	0.000169	0.000419	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SRD5A1—prostate cancer	0.000169	0.000419	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—VAV3—prostate cancer	0.000168	0.000415	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—ERBB2—prostate cancer	0.000168	0.000415	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000166	0.000412	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PDHA1—prostate cancer	0.000165	0.000409	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—UCP3—prostate cancer	0.000165	0.000409	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTA3—prostate cancer	0.000165	0.000409	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—TCN2—prostate cancer	0.000165	0.000409	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—EGFR—prostate cancer	0.000163	0.000403	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ACSL4—prostate cancer	0.000162	0.0004	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HSD17B3—prostate cancer	0.000162	0.0004	CbGpPWpGaD
Ibutilide—KCNJ11—Neuronal System—MDM2—prostate cancer	0.000161	0.000398	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—HSD3B1—prostate cancer	0.000158	0.00039	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SLC22A3—prostate cancer	0.000158	0.00039	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PHGDH—prostate cancer	0.000155	0.000383	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—UMPS—prostate cancer	0.000155	0.000383	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ARG2—prostate cancer	0.000155	0.000383	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—KRAS—prostate cancer	0.000154	0.000381	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—LDHB—prostate cancer	0.000152	0.000376	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—GSK3B—prostate cancer	0.000152	0.000376	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—TBXAS1—prostate cancer	0.000151	0.000374	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTA4—prostate cancer	0.000151	0.000374	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—LPL—prostate cancer	0.000149	0.000369	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP3A5—prostate cancer	0.000149	0.000369	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTA2—prostate cancer	0.000147	0.000364	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—CTNNB1—prostate cancer	0.000147	0.000363	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SULT1A1—prostate cancer	0.000145	0.00036	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ABCG5—prostate cancer	0.000145	0.00036	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—ITGB3—prostate cancer	0.000144	0.000357	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTA3—prostate cancer	0.000144	0.000356	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—UCP3—prostate cancer	0.000144	0.000356	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PDHA1—prostate cancer	0.000144	0.000356	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—TCN2—prostate cancer	0.000144	0.000356	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—MMP9—prostate cancer	0.000144	0.000356	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTA1—prostate cancer	0.000142	0.000351	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—HSD3B2—prostate cancer	0.00014	0.000347	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTO1—prostate cancer	0.00014	0.000347	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NAT2—prostate cancer	0.00014	0.000347	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—MMP2—prostate cancer	0.00014	0.000347	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—MAP2K1—prostate cancer	0.00014	0.000346	CbGpPWpGaD
Ibutilide—KCNH2—Neuronal System—MDM2—prostate cancer	0.000138	0.00034	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HSD3B1—prostate cancer	0.000137	0.00034	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SLC22A3—prostate cancer	0.000137	0.00034	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—EP300—prostate cancer	0.000136	0.000338	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PLCB2—prostate cancer	0.000135	0.000333	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—LRP2—prostate cancer	0.000135	0.000333	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP2C18—prostate cancer	0.000135	0.000333	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—SRC—prostate cancer	0.000133	0.000328	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—P4HB—prostate cancer	0.000132	0.000327	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—PPARA—prostate cancer	0.000132	0.000326	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTA4—prostate cancer	0.000132	0.000326	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—TBXAS1—prostate cancer	0.000132	0.000326	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—VEGFA—prostate cancer	0.000129	0.00032	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SLC22A1—prostate cancer	0.000128	0.000318	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTA2—prostate cancer	0.000128	0.000318	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—STAT3—prostate cancer	0.000128	0.000317	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—JAK2—prostate cancer	0.000128	0.000316	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SULT1A1—prostate cancer	0.000127	0.000314	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ABCG5—prostate cancer	0.000127	0.000314	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—IL6—prostate cancer	0.000125	0.00031	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SULT2A1—prostate cancer	0.000125	0.00031	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—LEP—prostate cancer	0.000125	0.00031	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTA1—prostate cancer	0.000124	0.000306	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—MED12—prostate cancer	0.000123	0.000305	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—ERBB2—prostate cancer	0.000123	0.000304	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—KDR—prostate cancer	0.000123	0.000303	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTO1—prostate cancer	0.000122	0.000303	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NAT2—prostate cancer	0.000122	0.000303	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HSD3B2—prostate cancer	0.000122	0.000303	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GNG5—prostate cancer	0.000122	0.000302	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—TGFB1—prostate cancer	0.000119	0.000293	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NCOA3—prostate cancer	0.000118	0.000291	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PLCB2—prostate cancer	0.000117	0.000291	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—LRP2—prostate cancer	0.000117	0.000291	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP2C18—prostate cancer	0.000117	0.000291	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—EGFR—prostate cancer	0.000116	0.000288	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—P4HB—prostate cancer	0.000115	0.000285	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000115	0.000285	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—HPGDS—prostate cancer	0.000112	0.000278	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SLC22A1—prostate cancer	0.000112	0.000277	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP2C19—prostate cancer	0.000112	0.000276	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—KRAS—prostate cancer	0.00011	0.000272	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SULT2A1—prostate cancer	0.000109	0.00027	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTT1—prostate cancer	0.000109	0.000269	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ACHE—prostate cancer	0.000109	0.000269	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—GSK3B—prostate cancer	0.000108	0.000268	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP2A6—prostate cancer	0.000108	0.000266	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—MED12—prostate cancer	0.000107	0.000266	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—INS—prostate cancer	0.000107	0.000264	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GNG5—prostate cancer	0.000107	0.000264	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—MMP9—prostate cancer	0.000105	0.000261	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—CREBBP—prostate cancer	0.000105	0.000259	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKR1C3—prostate cancer	0.000105	0.000259	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PRKACB—prostate cancer	0.000104	0.000258	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP17A1—prostate cancer	0.000103	0.000255	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NCOA3—prostate cancer	0.000103	0.000254	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—MMP2—prostate cancer	0.0001	0.000248	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—MAP2K1—prostate cancer	9.99e-05	0.000247	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NCOA2—prostate cancer	9.82e-05	0.000243	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—HPGDS—prostate cancer	9.79e-05	0.000242	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP2C19—prostate cancer	9.73e-05	0.000241	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—SRC—prostate cancer	9.72e-05	0.00024	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—FGF2—prostate cancer	9.51e-05	0.000235	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ACHE—prostate cancer	9.5e-05	0.000235	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTT1—prostate cancer	9.5e-05	0.000235	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—VEGFA—prostate cancer	9.47e-05	0.000234	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP2A6—prostate cancer	9.39e-05	0.000232	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SLC5A5—prostate cancer	9.37e-05	0.000232	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP2E1—prostate cancer	9.15e-05	0.000226	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKR1C3—prostate cancer	9.13e-05	0.000226	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—JAK2—prostate cancer	9.11e-05	0.000225	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PRKACB—prostate cancer	9.08e-05	0.000225	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NQO1—prostate cancer	9.05e-05	0.000224	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP17A1—prostate cancer	8.99e-05	0.000222	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—IL6—prostate cancer	8.94e-05	0.000221	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—TH—prostate cancer	8.92e-05	0.000221	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP3A4—prostate cancer	8.82e-05	0.000218	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—ERBB2—prostate cancer	8.77e-05	0.000217	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP1B1—prostate cancer	8.68e-05	0.000215	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NCOA2—prostate cancer	8.57e-05	0.000212	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—EGFR—prostate cancer	8.52e-05	0.000211	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GGT1—prostate cancer	8.4e-05	0.000208	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NCOA1—prostate cancer	8.28e-05	0.000205	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—AKT1—prostate cancer	8.25e-05	0.000204	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—SLC5A5—prostate cancer	8.17e-05	0.000202	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP19A1—prostate cancer	8.16e-05	0.000202	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—KRAS—prostate cancer	8.05e-05	0.000199	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP2E1—prostate cancer	7.98e-05	0.000197	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NQO1—prostate cancer	7.89e-05	0.000195	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—RXRA—prostate cancer	7.87e-05	0.000195	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—TH—prostate cancer	7.78e-05	0.000192	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP3A4—prostate cancer	7.7e-05	0.00019	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—CTNNB1—prostate cancer	7.67e-05	0.00019	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—COMT—prostate cancer	7.58e-05	0.000188	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP1B1—prostate cancer	7.57e-05	0.000187	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTP1—prostate cancer	7.55e-05	0.000187	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—MMP9—prostate cancer	7.52e-05	0.000186	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ITPR1—prostate cancer	7.43e-05	0.000184	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GGT1—prostate cancer	7.33e-05	0.000181	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NCOA1—prostate cancer	7.22e-05	0.000179	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—EP300—prostate cancer	7.13e-05	0.000176	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP19A1—prostate cancer	7.11e-05	0.000176	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—TYMS—prostate cancer	7.02e-05	0.000174	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—GSTM1—prostate cancer	6.94e-05	0.000172	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—SRC—prostate cancer	6.94e-05	0.000172	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—RXRA—prostate cancer	6.87e-05	0.00017	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—LPL—prostate cancer	6.81e-05	0.000168	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—VEGFA—prostate cancer	6.75e-05	0.000167	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—STAT3—prostate cancer	6.69e-05	0.000165	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—COMT—prostate cancer	6.61e-05	0.000164	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTP1—prostate cancer	6.58e-05	0.000163	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP1A1—prostate cancer	6.58e-05	0.000163	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—IL6—prostate cancer	6.55e-05	0.000162	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—ERCC2—prostate cancer	6.52e-05	0.000161	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ITPR1—prostate cancer	6.48e-05	0.00016	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—TGFB1—prostate cancer	6.2e-05	0.000153	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—MTHFR—prostate cancer	6.13e-05	0.000152	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—TYMS—prostate cancer	6.12e-05	0.000151	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—EGFR—prostate cancer	6.08e-05	0.00015	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—GSTM1—prostate cancer	6.05e-05	0.00015	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PPARA—prostate cancer	6.01e-05	0.000149	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—LPL—prostate cancer	5.94e-05	0.000147	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—KRAS—prostate cancer	5.74e-05	0.000142	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP1A1—prostate cancer	5.74e-05	0.000142	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—ERCC2—prostate cancer	5.69e-05	0.000141	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CAV1—prostate cancer	5.65e-05	0.00014	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—MTHFR—prostate cancer	5.35e-05	0.000132	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PPARA—prostate cancer	5.25e-05	0.00013	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PIK3CG—prostate cancer	5.15e-05	0.000127	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CAV1—prostate cancer	4.93e-05	0.000122	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—INS—prostate cancer	4.88e-05	0.000121	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CREBBP—prostate cancer	4.77e-05	0.000118	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—IL6—prostate cancer	4.67e-05	0.000116	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PIK3CD—prostate cancer	4.53e-05	0.000112	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PIK3CG—prostate cancer	4.49e-05	0.000111	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—AKT1—prostate cancer	4.31e-05	0.000107	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NOS3—prostate cancer	4.28e-05	0.000106	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—INS—prostate cancer	4.25e-05	0.000105	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CREBBP—prostate cancer	4.16e-05	0.000103	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PIK3CD—prostate cancer	3.95e-05	9.77e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PIK3CB—prostate cancer	3.95e-05	9.76e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PTGS2—prostate cancer	3.91e-05	9.67e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NOS3—prostate cancer	3.73e-05	9.22e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PIK3CB—prostate cancer	3.44e-05	8.51e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PTGS2—prostate cancer	3.41e-05	8.44e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PTEN—prostate cancer	3.41e-05	8.44e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—EP300—prostate cancer	3.25e-05	8.04e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PTEN—prostate cancer	2.97e-05	7.36e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—EP300—prostate cancer	2.84e-05	7.02e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PIK3CA—prostate cancer	2.41e-05	5.95e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PIK3CA—prostate cancer	2.1e-05	5.19e-05	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKT1—prostate cancer	1.97e-05	4.86e-05	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKT1—prostate cancer	1.71e-05	4.24e-05	CbGpPWpGaD
